• News
  • SAN DIEGO
  • Finance

Isis jumps as FDA clears cholesterol treatment

Isis Pharmaceuticals Inc. rose to its highest value in four months after receiving U.S. approval for a drug to treat a rare form of high cholesterol.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!